TGFB1 and neoplasm: Unlike normal DCs, this aberrant DC phenotype suppresses the production of pro-inflammatory mediators, such as TNF-α and IL-12, while augmenting the secretion of pro-tumor proteins, including VEGF (Vascular endothelial growth factor), IL-6, TGF-β, IL-8, and IL-10 37.